Trial intelligence / Profile preview

Omega-3 Enriched Nutrition in Critical Illness

NCT01162928Phase 3Completed

Sponsor
B. Braun
Start
May 2013
Primary completion
Nov 2017
Modality
Recombinant Proteins and Enzymes, Lipid-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Nutriflex Omega special in critical illness, sponsored by B. Braun. Started May 2013; status: completed.

02

Drugs

Nutriflex Omega special
03

Conditions

critical illness

Beyond the preview

Go deeper on NCT01162928.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01162928.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call